New Framework for Treating Neuropsychiatric Conditions in Pediatric Epilepsy

Strategic Insights -

Researchers from the Kennedy Krieger Institute have developed a new approach to initiating pharmacologic treatment for children and adolescents with epilepsy who present with comorbid neuropsychiatric symptoms. The framework provides practical, evidence-informed guidance on determining when medication is warranted, selecting medications, and monitoring treatment. This approach aims to optimize both neurological and psychiatric outcomes in this complex population.

Key Takeaways:

  • The study proposes a decision-making framework for clinicians to optimize neurological and psychiatric outcomes in pediatric epilepsy patients with comorbid neuropsychiatric symptoms.
  • The framework considers factors such as the severity of neuropsychiatric symptoms, the presence of other medical conditions, and the patient's response to medication.
  • The approach outlines principles for medication initiation and monitoring, including regular follow-up appointments and adjustments to medication regimens as needed.
  • The study's authors emphasize the importance of a collaborative approach between clinicians, patients, and families in managing comorbid neuropsychiatric symptoms in pediatric epilepsy.
  • The framework is applicable to patients of all ages, not just pediatric populations.
  • The study's authors note that the approach is based on current evidence and clinical expertise, but emphasizes the need for further research to refine the framework.

Names, Organizations, and Initiatives:

  • Kennedy Krieger Institute, Neuropsychiatry Program
  • Jay A. Salpekar, lead author of the study
  • Sage Publications Inc, publisher of Epilepsy Currents

Statistics:

  • The study did not report any specific numerical data on the prevalence of comorbid neuropsychiatric symptoms in pediatric epilepsy patients.
  • The framework is based on current evidence and clinical expertise, but the study's authors emphasize the need for further research to refine the approach.
  • The study suggests that a collaborative approach between clinicians, patients, and families is essential for managing comorbid neuropsychiatric symptoms in pediatric epilepsy.

Sources:

  • Kennedy Krieger Institute
  • Epilepsy Currents (2025)
  • Sage Publications Inc (www.wiley.com/)
  • Jay A. Salpekar, Kennedy Krieger Institute, Neuropsychiatry Program, 1741 Ashland Ave, Baltimore, MD 21205, United States.